Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2008
10/23/2008US20080261271 Expression of hiv polypeptides and production of virus-like particles
10/23/2008US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
10/23/2008US20080260865 Methods for Treating Bacterial Respiratory Tract Infections in an Individual Using Acidified Nitrite
10/23/2008US20080260835 Bioavailability; solid dispersion; dosage forms
10/23/2008US20080260822 SYNTHESIS OF HUMAN SECRETORY IgA AND IgM AND THE FORMATION OF A MEDICAMENT THEREFROM
10/23/2008US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification
10/23/2008US20080260806 Towelette containing astringent, humectant and botanical extract; cleaning, deodorizing; safe for sensitive skin
10/23/2008US20080260804 Inhibiting microorganism adhesion and colonization on extended wear contact lenses; functionalizing and multilayer surface coupling such as polydiallyldimethylammonium chloride using polyacrylic acid and polyallylamine hydrochloride
10/23/2008US20080260788 Antiseptic; mixture of alcohol and halogen compound; bactericides, viricides, fungicides
10/23/2008US20080260781 Proteosome influenza vaccine
10/23/2008US20080260780 Materials and methods relating to improved vaccination strategies
10/23/2008US20080260779 Administering portcine circovirus type-2 antigen; therapy for infections such as lymphadenopathy, lymphoid depletion and nucxleation histocytes ; veterinary medicine
10/23/2008US20080260777 Antigen to stimulate immunology response in inoculated avian species; contains seven strains of Escherichia
10/23/2008US20080260766 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti-HIV-1 prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention
10/23/2008US20080260734 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
10/23/2008US20080260698 Chimeric sindbis-western equine encephalitis virus and uses thereof
10/23/2008US20080260697 Using controlled release bacteriophage as therapeutic to manage feedlot target pathogens; reducing pathogenic microorganisms in animal enclosures
10/23/2008US20080260691 Conjugated with amino acids, peptides, glycopeptides; bioavailability
10/23/2008US20080260688 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/23/2008US20080260687 Identifying modulators which interfere with interleukin-6 and interleukin-6 receptor binding; antitumor agents; treating cell proliferative disorders
10/23/2008US20080260659 Personal care product containing preservative and benzaldehyde enhancer
10/23/2008US20080260656 Ungual/periungual compositions comprising morpholine compounds and water-soluble film-forming agents
10/23/2008CA2783587A1 Method for manufacturing neuraminic acid derivatives
10/23/2008CA2703011A1 Oxazolidinone derivatives and methods of use
10/23/2008CA2688693A1 Interferons of rhesus and cynomolgus origin and uses thereof
10/23/2008CA2684494A1 Fusion protein vaccine
10/23/2008CA2684103A1 Delivery of flu antibodies to surfaces in contact with air
10/23/2008CA2683919A1 Benzofuran- carboxamide derivatives as antiviral agents
10/23/2008CA2683778A1 Prevention of staphylococcus biofilm formation
10/23/2008CA2679071A1 Oxazolidinone antibiotics
10/23/2008CA2679069A1 Oxazolidinone antibiotic derivatives
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1983047A1 Novel viral vector
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982986A1 Pyrrolopyridazinone compound
10/22/2008EP1982732A2 Factor VII or VIIA-like molecules
10/22/2008EP1982728A1 Peptide derived from hepatitis c virus
10/22/2008EP1982726A1 Novel vaccine carrier
10/22/2008EP1982725A1 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa
10/22/2008EP1982723A1 Immobilisation and stabilisation of virus
10/22/2008EP1982717A1 Use of fungicides for treating fish mycoses
10/22/2008EP1982715A1 Use of fungicides for treating fish mycoses
10/22/2008EP1982696A1 Gel for treating wounds
10/22/2008EP1982008A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration
10/22/2008EP1981911A2 Synergistic compositions for treating hiv
10/22/2008EP1981881A1 Tetrahydropyrane antibiotics
10/22/2008EP1981876A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
10/22/2008EP1981845A2 Sulfonamide derivatives to treat infection with hepatitis c virus
10/22/2008EP1981844A1 Novel lactams
10/22/2008EP1981838A2 Process for synthesis of glycomimicking cationic amphiphiles
10/22/2008EP1981535A2 Compositions and methods of modulating the immune response
10/22/2008EP1981524A2 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto
10/22/2008EP1981523A2 Novel hcv inhibitor combinations and methods
10/22/2008EP1981506A2 Long term treatment of hiv- infection with tcm278
10/22/2008EP1877411A4 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
10/22/2008EP1778271B1 Peptides for the treatment of herpes virus infections
10/22/2008EP1654228B1 Tetrahydrocarbazole derivatives and their pharmaceutical use
10/22/2008EP1583542B9 Compositions and methods for combination antiviral therapy
10/22/2008EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
10/22/2008EP1417196B1 Dna-pk inhibitors
10/22/2008EP1408984B1 Organo-phosphorous compounds for activating gamma/delta t cells
10/22/2008EP1365755B1 Use of pyrimidine nucleosides and/or the prodrugs thereof for combating the side-effects of haart (highly active anti-retroviral therapy) and other anti-viral therapies
10/22/2008EP1319009B1 Intermediates in cephalosporin production
10/22/2008EP1307565B1 Vaccins against marek's disease virus (mdv) and varicella zoster virus (vzv)
10/22/2008EP1041888B1 Anti-retroviral immunogens, preparation and use
10/22/2008EP0854729B2 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
10/22/2008EP0787011B1 microemulsion preconcentrate comprising a macrolide
10/22/2008CN101292039A Method for producing cercosporamide
10/22/2008CN101291949A Aptamers comprising arabinose modified nucleotides
10/22/2008CN101291946A Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
10/22/2008CN101291928A 4-heteroarylmethyl substituted phthalazinone derivatives
10/22/2008CN101291923A Pyrazolone derivatives for the treatment of tuberculosis
10/22/2008CN101291905A Phenyl-acetamide nnrt inhibitors
10/22/2008CN101289658A Recombination virus particles for expressing 2-typed porcine circovirus nucleocapsid protein Cap gene
10/22/2008CN101289657A Recombination porcine parvovirus VP2 virus particles for expressing exogenous gene
10/22/2008CN101289501A Pokeweed antibiotic peptides, precursor peptides thereof, polynucleotide and applications
10/22/2008CN101289500A Long lasting fusion peptide inhibitor of viral infection
10/22/2008CN101289496A Epitope screening method capable of exciting anti-mycobacterium tuberculosis protective immunological reaction of body and uses
10/22/2008CN101289484A Macrolides with antibacterial activity
10/22/2008CN101289483A Macrolides with antibacterial activity
10/22/2008CN101289472A Process for separating matrine-like total alkaloids form Chinese medicament extract
10/22/2008CN101289459A Cephalosporin derivatives with nitrogen-onium ion azazocyclo
10/22/2008CN101289457A Novel process for synthesizing 3-deacetyl cefuroxime sodium (DCCF)
10/22/2008CN101289456A Method for synthesizing cefuroxime sodium
10/22/2008CN101289440A Polyene macrocyclic compounds, preparation thereof and applications
10/22/2008CN101289416A High-water-solubility florfenicol prodrug quickly released in vivo
10/22/2008CN101288770A New herpes simplex virus type II DNA vaccine
10/22/2008CN101288769A Bactericide for pet and preparation method thereof
10/22/2008CN101288755A Medicine for treating onychomycosis and
10/22/2008CN101288714A Orally-taken Chinese medicine for treating bacillary dysentery
10/22/2008CN101288694A Preparation method of magnolia bark extracts with no residual solvent, low oiliness and high content
10/22/2008CN101288681A Preparation technique of ginkgo leaf extract
10/22/2008CN101288676A New application of hexadecanoyl-sulfonic-glycerol-glucose ester and its preparation method
10/22/2008CN101288674A New dosage medicinal application and using method of adefovir dipivoxil
10/22/2008CN101288668A Disinfectant constitutes
10/22/2008CN101288665A Medicine containing alkannin compound as active component
10/22/2008CN101288661A Fenticonazole nitrate vaginal effervescent tablets and preparation method thereof
10/22/2008CN101288655A Itraconazole sustained-release drop pills and preparation method thereof
10/22/2008CN101288646A Lipid nanoparticles with anti-hepatitis B activity and application
10/22/2008CN101288643A Gel composition containing tacrolimu and its preparation method and medicinal application